Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yup , Best Veh to Invest/ Trade in ,& better way to go.. if Karmella gets installed Roths wont be effected by her ,looking forward to taking distributions from mine in 2025 once BTC peeks
It's a different world here in Canada.
Securities that trade only on OTC markets are not considered qualified investments for TFSAs(tax free savings account) and RRSPs(registered retirement savings plan)
The Canada Revenue Agency (CRA) states that "securities that trade on OTC markets are generally not qualified investments."
However, American Depositary Receipts (ADRs), may be qualified investments if the underlying security is listed on a designated stock exchange. 🙁
Hope you have lots of Tylenol on hand.....💊🤣
https://www.shopify.com/ca/blog/operating-income-vs-net-income
You gave me a headache, lol
I have that problem too. 33% of mine are not in a Roth IRA.
I converted a few way before you did.
Ratios & Margins Elite Pharmaceuticals Inc.
Valuation
P/E Ratio (TTM) 20.36
P/E Ratio (including extraordinary items) 21.30
Price to Sales Ratio 0.86
Price to Book Ratio 1.02
Price to Cash Flow Ratio 8.80
Enterprise Value to EBITDA 33.98
Enterprise Value to Sales 6.30
Total Debt to Enterprise Value 0.15
Total Debt to EBITDA 0.73
Efficiency
Revenue/Employee 644,436
Income Per Employee 67,205
Receivables Turnover 11.10
Total Asset Turnover 0.90
Liquidity
Current Ratio 2.75
Quick Ratio 1.53
Cash Ratio 0.54
Profitability
Gross Margin +44.89
Operating Margin +11.62
Pretax Margin +11.67
Net Margin +10.43
Return on Assets 9.37
Return on Equity 13.15
Return on Total Capital 13.04
Return on Invested Capital 11.88
Capital Structure
Total Debt to Total Equity 13.42
Total Debt to Total Capital 11.83
Total Debt to Total Assets 9.51
Interest Coverage 3.57
Long-Term Debt to Equity 12.30
Long-Term Debt to Total Capital 10.84
Long-Term Debt to Assets 0.09
Thx for sharing our time here together. More to come !!!!!
$$$$$$$
Better than I’m out and you’re still posting .
Sure, I'd be happy to explain the difference between net profit and operating profit!
**Operating Profit**:
- **Definition**: Operating profit, also known as operating income, is the profit a company makes from its core business operations. It excludes any income or expenses from non-operational activities, such as interest and taxes.
- **Calculation**: It is calculated as:
$$
\text{Operating Profit} = \text{Gross Profit} - \text{Operating Expenses}
$$
Here, gross profit is the revenue minus the cost of goods sold (COGS), and operating expenses include costs like rent, utilities, payroll, and depreciation¹².
**Net Profit**:
- **Definition**: Net profit, also known as net income, is the total profit of a company after all expenses have been deducted from total revenue. This includes operating expenses, interest, taxes, and any other non-operational costs.
- **Calculation**: It is calculated as:
$$
\text{Net Profit} = \text{Total Revenue} - \text{Total Expenses}
$$
Total expenses include operating expenses, interest, taxes, and any other costs¹².
**Key Differences**:
1. **Scope of Expenses**: Operating profit only considers operating expenses, while net profit includes all expenses, including interest and taxes.
2. **Indicator of Performance**: Operating profit provides insight into the profitability of core business operations, whereas net profit gives a complete picture of overall profitability.
3. **Position on Income Statement**: Operating profit is listed before net profit on the income statement, as it is calculated before deducting interest and taxes¹².
Understanding these differences can help you better analyze a company's financial health and operational efficiency. Do you have any specific companies or financial metrics you're looking into?
Source: Conversation with Copilot, 9/19/2024
(1) Operating Profit vs. Net Profit Differences - WallStreetMojo. https://www.wallstreetmojo.com/operating-profit-vs-net-profit/.
(2) Operating Profit vs. Net Income: What's the Difference? - Investopedia. https://www.investopedia.com/ask/answers/122414/operating-profit-same-net-income.asp.
(3) Gross vs. Operating vs. Net Profit: 4 Key Differences. https://www.indeed.com/career-advice/career-development/gross-vs-net-vs-operating-profit.
Thank you. That is a lesson for me. I do have a portion of my position out of my IRA
Roth IRA you pay taxes up front and not at withdrawal.
Another question out of curiosity. What is the difference between net profit and operating profit?
True but I pay taxes in average based on 15 cents. Not at $3.5 or more a share.
Curious. How are they tax free? Even if it is in IRA, when withdrawn, some tax needs to be paid, right?
Anyone who did a Roth conversion with fidelity please give a thumbs up. I have news for you.
Yessssirreeee!!!!!!$$$$$$$$$$$ELTP
Same here.
Strategy
Risk management
Plays
I would not have my shares if not for you SIR NASDAQ2020 thank you !!!!!!$$$$$$$$$$$$$$$$$$$$$$$$Eltp
2011 ever more
Heck yeah!
For Real!!!!
Locked, loaded and tax free.
My shares are locked and loaded thanks for all you do NASDAQ2020 for real 😎$$$$$$$$$$$$$$$$$$$
Where are your shares ?
KEY STATS
Open
0.395
Day High
0.407
Day Low
0.375
Prev Close
0.3875
52 Week High
0.42
52 Week High Date
09/12/24
52 Week Low
0.08
52 Week Low Date
09/19/23
Market Cap
415.451M
Shares Out
1.07B
10 Day Average Volume
4.45M
Beta
0.13
YTD % Change
177.79
RATIOS/PROFITABILITY
EPS (TTM)
0.02
P/E (TTM)
20.33
EBITDA (TTM)
14.528M
ROE (TTM)
44.32%
Revenue (TTM)
66.448M
Gross Margin (TTM)
45.27%
Net Margin (TTM)
29.47%
Debt To Equity (MRQ)
16.13%
Absolutely. Vyvanse may get delayed. OxyContin may get kicked down road for several years. We do know for certain what will be launching over next several months - that alone is a huge win. We haven’t seen any new positive BE trial for a while - lots of R&D being spent. Would love to see a couple in quick succession hit the wire.
That’s bull shit Jammy,, the sentiment has changed ? In your head. You sold your shares and want back in. Often a warning sign ? Start taking your medication and stop the lying.
When the short interest of a company increases, it is often a warning sign that the stock sentiment is bearish (negative) and that investors expect the stock price to decline.
Laz...so nice to read
At this point in my life im happy to see green in the a.m.
Honestly...if I see even close to the lower number, it will
be the top-off of great exciting life.
I dont hve any problem if you revise upward.
Who are you talking to? Random people that might read the board?
Can you tell me what trial announcement is coming? Lol
Agree with you It’s just so many cocky people claiming we will all be millionaires and making wild predictions Let’s get them approved first
You would be required to be here if those items weren't going to happen. In fact, anyone that did the opposite of you is up around 700% right now
Your boss is still very short. Just need to light that fire ....
Bag of Doritos...
I thought about that case scenario many of times but eltp keeps on producing bigger revenues and higher profits. I do believe eltp is in a sweet spot with many generic drugs trying to get approval, bigger facility is around the corner, and more publicity of the stock itself.
CrypticPhoenix9
One posted message and it's about the short interest being higher. I'm hoping for increase in higher short interest so they can eat dirt and need to cover in the future. Going forward, eltp needs to execute the approval of generic drugs by the FDA and it wouldn't hurt if we get some positive news from ELTP before 2nd quarter earnings.
I know I know Did anyone ever think that maybe all these things “to come” may not come There is a possibility there could be a few denials Like when my friends bet on a game and they say “Don’t worry it’s a lock” lol
Remember folks, there is an ez conservative looking path to $1.00 before the end of the year. Where else can you get 150% return that's almost guaranteed?
Nice green close; just a playing that old fiddle as normal
Elite held the session in green territory, but volume is softening. It’s just a game of timing for what’s to come - facility approval, launches, BE studies, FDA approvals, etc. All good things, all good things.
Exactly bubba, too much ra ra and toppin off. Can we hit .50 ?
Market up 500 Elite down Maybe wanna dial back the lofty dreams of 4,5,6 dollars a share when we can’t hold 40 cents
It does that sometimes when you are swapping back and forth with your alt accounts...lol. Ignored.
Can you tell us what they are, the market value of each and the pdufa date? If you can answer those questions, I bet we can answer your question.
Bet you won't
Turkey and cheese for you. You are welcome.
Followers
|
999
|
Posters
|
|
Posts (Today)
|
9
|
Posts (Total)
|
409264
|
Created
|
03/24/09
|
Type
|
Free
|
Moderators jimr1717 mrwrn2010 NASDAQ2020 IB_ namtae Dr JoeBarducci |
Senior Moderator: IB_
Posted: 7/02/2024
________________________________________________________________________________________________________________
Elite Pharmaceuticals, Inc. |
Website | Location | Employees | Facility | CEO |
www.elitepharma.com | Northvale, New Jersey | 64 | 85,000 sq ft | Nasrat Hakim |
Products & Pipeline | ||||
Drug | Market Size | Status | Competitors | Marketed By |
Adderall IR | 389.8 M | On Market | 15 | Elite |
Adderall XR | 1.56 B | On Market | 10 | Elite & Prasco |
Dantrolene | 6.3 M | On Market | 2 | Elite |
Isradipine | 5.5 M | On Market | 1 | Elite |
Loxapine | 5 M | On Market | 2 | Elite |
Phendimetrazine | 4.5 M | On Market | 4 | Elite |
Trimipramine | 2 M | On Market | 1 | Elite |
Naltrexone | 16 M | On Market | 5 | Precision Dose |
Phentermine Capsules | 7.5 M | On Market | 6 | Precision Dose |
Phentermine Tablets | 40 M | On Market | 8 | Precision Dose |
Vigabatrin | 233.7 M | On Market | 13 | Pyros |
Doxycycline | 85 M | Approved (Discontinued) | 9 | ---------- |
Tylenol with Codeine | 45 M | Approved in Launch Queue | 5 | ---------- |
Dopamine Agonist | 12 M | Filed with FDA - 22 Dec 2022 | ---------- | ---------- |
Methotrexate | 63.4M | On Market | 8 | Elite |
Percocet | 500 M | Approved in Launch Queue | 14 | ---------- |
Norco | 477 M | Approved in Launch Queue | 12 | ---------- |
Methadone | 30 M | Approved in Launch Queue | 8 | ---------- |
OxyContin | 720 M | Filed with FDA - 17 Aug 2023 | ??? | ---------- |
Vyvanse | 5.10 B | Filed with FDA - 21 Dec 2023 | 11 | ---------- |
Concerta | 1.16 B | In Development (Final Stages) | 8 | ---------- |
Financials | ||||
Fiscal Year | Revenue | Change | Net Income | Change |
2019 | 7,568,508 | ---------- | (9,279,321) | ---------- |
2020 | 17,994,639 | +137.76% | (2,240,351) | +75.86% |
2021 | 25,380,749 | +41.05% | 5,088,421 | +327.13% |
2022 | 32,262,117 | +27.11% | 8,898,245 | +74.87% |
2023 | 34,155,114 | +5.87% | 3,561,846 | -59.97% |
2024 | 56,625,128 | +65.79% | 20,108,631 | +464.56% |
2025 Q-1 | 18,803,063 | +109.39% | 3,864,056 | +144.00% |
2025 Q-2 | ||||
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |